Predicting responsiveness to GLP-1 pathway drugs using real-world data
Zhu X, Fowler MJ, Wells QS, et al.
BMC Endocr Disord. 2024;24(1):269.
Leggi
Hybrid closed-loop insulin therapy and risk of severe hypoglycaemia and diabetic ketoacidosis in young people (aged 2-20 years) with type 1 diabetes: a population-based study
Karges B, Rosenbauer J, Stahl-Pehe A, et al.
Lancet Diabetes Endocrinol. 2024:S2213-8587(24)00284-5.
Leggi
Association between time in tight range and incident diabetic retinopathy in adults with type 2 diabetes
Wang Y, Lu J, Yu J, et al.
Diabetes Obes Metab. Pub. online 18 Dec 2024.
Leggi
SURVEY AMD – UTILIZZO DELLE TECNOLOGIE NEL DT1
Carissimi Soci, una nuova indagine dedicata all’utilizzo delle tecnologie per la gestione dell’adulto con diabete tipo 1, con particolare riferimento ai sistemi con automatismo. Il vostro prezioso contributo ci aiuterà a mappare e comprendere il vissuto dei diabetologi rispetto alle nuove tecnologie e ai sistemi ibridi AHCL. Per rispondere al…
Leggi
Precision medicine in type 1 diabetes: comparing metabolic outcomes of Control-IQ and MiniMed 780G according to patient characteristics
Gargouri I, Charfi H, Belabed W, et al.
Diabetes Obes Metab. Pub. online 17 Dec 2024.
Leggi
Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment
Stefan N, Yki-Järvinen H, Neuschwander-Tetri BA
Lancet Diabetes Endocrinol. Pub. online 13 Dec 2024.
Leggi
Association between glycemia, glycemic variability, and pregnancy complications in early GDM
Immanuel J, Cheung NW, Mohajeri M, et al.
Diabetes Care. 2024:dc241199
Leggi
Towards standardization of person-reported outcomes (PROs) in pediatric diabetes research: a consensus report
Barnard-Kelly K, Marrero D, de Wit M, et al. Diabet Med. 2024:e15484 Abstract
Leggi
Finerenone, obesity, and heart failure with mildly reduced/preserved ejection fraction: prespecified analysis of FINEARTS-HF
Butt JH, Henderson AD, Jhund PS, et al.
J Am Coll Cardiol. 2024:S0735-1097(24)10423-8.
Leggi